BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 16174241)

  • 1. Results of radiotherapy alone in the treatment of carcinoma of uterine cervix: a retrospective analysis of 1069 patients.
    Saibishkumar EP; Patel FD; Sharma SC
    Int J Gynecol Cancer; 2005; 15(5):890-7. PubMed ID: 16174241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Results of external-beam radiotherapy alone in invasive cancer of the uterine cervix: a retrospective analysis.
    Saibishkumar EP; Patel FD; Sharma SC; Karunanidhi G; Sankar AS; Mallick I
    Clin Oncol (R Coll Radiol); 2006 Feb; 18(1):46-51. PubMed ID: 16477919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of late toxicities of patients with carcinoma of the cervix treated with radical radiotherapy: an audit from India.
    Saibishkumar EP; Patel FD; Sharma SC
    Clin Oncol (R Coll Radiol); 2006 Feb; 18(1):30-7. PubMed ID: 16477917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An audit of the treatment of carcinoma of the uterine cervix using external beam radiotherapy and a single line source brachytherapy technique.
    Tan LT; Jones B; Gee A; Kingston RE
    Br J Radiol; 1997 Dec; 70(840):1259-69. PubMed ID: 9505845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of response to external radiation in stage IIIB cancer cervix in predicting clinical outcomes: a retrospective analysis of 556 patients from India.
    Saibishkumar EP; Patel FD; Sharma SC; Karunanidhi G; Ghoshal S; Kumar V; Kapoor R
    Radiother Oncol; 2006 May; 79(2):142-6. PubMed ID: 16677730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carcinoma of the uterine cervix. I. Impact of prolongation of overall treatment time and timing of brachytherapy on outcome of radiation therapy.
    Perez CA; Grigsby PW; Castro-Vita H; Lockett MA
    Int J Radiat Oncol Biol Phys; 1995 Jul; 32(5):1275-88. PubMed ID: 7635767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term results of high-dose rate intracavitary brachytherapy for squamous cell carcinoma of the uterine cervix.
    Nakano T; Kato S; Ohno T; Tsujii H; Sato S; Fukuhisa K; Arai T
    Cancer; 2005 Jan; 103(1):92-101. PubMed ID: 15540233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective multi-institutional study of definitive radiotherapy with high-dose-rate intracavitary brachytherapy in patients with nonbulky (<4-cm) stage I and II uterine cervical cancer (JAROG0401/JROSG04-2).
    Toita T; Kato S; Niibe Y; Ohno T; Kazumoto T; Kodaira T; Kataoka M; Shikama N; Kenjo M; Tokumaru S; Yamauchi C; Suzuki O; Sakurai H; Numasaki H; Teshima T; Oguchi M; Kagami Y; Nakano T; Hiraoka M; Mitsuhashi N
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):e49-56. PubMed ID: 21470794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose-rate intracavitary brachytherapy combined with external beam radiotherapy for stage IIIb adenocarcinoma of the uterine cervix in Japan: a multi-institutional study of Japanese Society of Therapeutic Radiology and Oncology 2006-2007 (study of JASTRO 2006-2007).
    Niibe Y; Kenjo M; Onishi H; Ogawa Y; Kazumoto T; Ogino I; Tsujino K; Harima Y; Takahashi T; Anbai A; Tsuchida E; Toita T; Takemoto M; Yamashita H; Hayakawa K
    Jpn J Clin Oncol; 2010 Aug; 40(8):795-9. PubMed ID: 20444747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radical radiotherapy treatment (EBRT + HDR-ICRT) of carcinoma of the uterine cervix: outcome in patients treated at a rural center in India.
    Jain VS; Singh KK; Shrivastava R; Saumsundaram KV; Sarje MB; Jain SM
    J Cancer Res Ther; 2007; 3(4):211-7. PubMed ID: 18270396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term outcome and prognostic factors in patients with cervical carcinoma: a retrospective study.
    Atahan IL; Onal C; Ozyar E; Yiliz F; Selek U; Kose F
    Int J Gynecol Cancer; 2007; 17(4):833-42. PubMed ID: 17367320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dosimetric parameters that predict late rectal complications after curative radiotherapy in patients with uterine cervical carcinoma.
    Hyun Kim T; Choi J; Park SY; Lee SH; Lee KC; Yang DS; Shin KH; Cho KH; Lim HS; Kim JY
    Cancer; 2005 Sep; 104(6):1304-11. PubMed ID: 16078262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Preoperative concurrent radiation therapy and chemotherapy for operable bulky carcinomas of uterine cervix stages IB2, IIA, and IIB with proximal parametrial invasion].
    Lerouge D; Touboul E; Lefranc JP; Uzan S; Jannet D; Moureau-Zabotto L; Genestie C; Antoine M; Jamali M
    Cancer Radiother; 2004 Jun; 8(3):168-77. PubMed ID: 15217584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative concurrent radiation therapy and chemotherapy for bulky stage IB2, IIA, and IIB carcinoma of the uterine cervix with proximal parametrial invasion.
    Huguet F; Cojocariu OM; Levy P; Lefranc JP; Darai E; Jannet D; Ansquer Y; Lhuillier PE; Benifla JL; Seince N; Touboul E
    Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1508-15. PubMed ID: 18676093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary radiotherapy of stage IIA/B-IIIB cervical carcinoma. A comparison of continuous versus sequential regimens.
    Mayer A; Nemeskéri C; Petneházi C; Borgulya G; Varga S; Naszály A
    Strahlenther Onkol; 2004 Apr; 180(4):209-15. PubMed ID: 15057431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postoperative radiotherapy in early stage carcinoma of the uterine cervix: treatment results and prognostic factors.
    Yeh SA; Wan Leung S; Wang CJ; Chen HC
    Gynecol Oncol; 1999 Jan; 72(1):10-5. PubMed ID: 9889023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interdigitated versus sequential high-dose-rate intracavitary brachytherapy with external beam radiotherapy in locally advanced carcinoma cervix.
    Alam N; Akram M; Siddiqui SA; Hussain MAB
    J Cancer Res Ther; 2019; 15(6):1254-1259. PubMed ID: 31898656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. De-escalation of the cumulative central radiation dose according to the tumor response can reduce rectal toxicity without compromising the treatment outcome in patients with uterine cervical cancer.
    Kim KH; Kim S; Kim GE; Koom WS; Kim SW; Nam EJ; Suh CO; Kim YB
    Gynecol Oncol; 2015 Dec; 139(3):439-46. PubMed ID: 26456139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is there a role for adjuvant hysterectomy after suboptimal concurrent chemoradiation in cervical carcinoma?
    Walji N; Chue AL; Yap C; Rogers LJ; El-Modir A; Chan KK; Singh K; Fernando IN
    Clin Oncol (R Coll Radiol); 2010 Mar; 22(2):140-6. PubMed ID: 20045300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extended-field radiotherapy and high-dose-rate brachytherapy in carcinoma of the uterine cervix: clinical experience with and without concomitant chemotherapy.
    Sood BM; Gorla GR; Garg M; Anderson PS; Fields AL; Runowicz CD; Goldberg GL; Vikram B
    Cancer; 2003 Apr; 97(7):1781-8. PubMed ID: 12655536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.